Avidity
Evan Maher currently serves as the Director of Commercial Planning at Avidity Biosciences, Inc., a position held since January 2025. Prior experience includes significant roles at BioMarin Pharmaceutical Inc., where Evan held multiple positions from August 2018 to January 2025, including Associate Director of Commercial Program and Alliance Management, Senior Manager of Global Business Operations, and Manager of Global Commercial Operations. Earlier experience at Shire involved the role of Project Manager in US Commercial Operations for a brief period in 2018. Evan's career at BioMarin also featured a tenure from July 2013 to April 2017, with roles such as Manager of Global Commercial Operations and Regulatory Affairs Manager. Academic qualifications include a Master of Business Administration (MBA) and a Bachelor of Science in Business Administration, both obtained from California State University, Chico.
This person is not in any teams
Avidity
2 followers
Avidity Biosciences is pioneering a new class of precision medicines – antibody-siRNA conjugates (ASC™) – to deliver nucleic acid therapeutics against genetic drivers of disease. Our ASCs have drug-like properties similar to antibodies and antibody-drug conjugates. Importantly, their unique siRNA-based “payloads” permit selective targeting of disease-associated mRNAs against virtually any target of interest.